A072020 Stock Overview
Operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Choong Ang Vaccine Laboratory Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,200.00 |
| 52 Week High | ₩11,630.00 |
| 52 Week Low | ₩9,000.00 |
| Beta | 0 |
| 1 Month Change | 5.26% |
| 3 Month Change | -2.39% |
| 1 Year Change | -5.56% |
| 3 Year Change | -30.61% |
| 5 Year Change | -45.01% |
| Change since IPO | 160.43% |
Recent News & Updates
Recent updates
Here's Why Choong Ang Vaccine Laboratory (KOSDAQ:072020) Can Manage Its Debt Responsibly
Mar 08
Here's What Choong Ang Vaccine Laboratory Co., Ltd.'s (KOSDAQ:072020) Shareholder Ownership Structure Looks Like
Feb 15
The Choong Ang Vaccine Laboratory (KOSDAQ:072020) Share Price Has Gained 32% And Shareholders Are Hoping For More
Jan 19Is Choong Ang Vaccine Laboratory Co., Ltd.'s (KOSDAQ:072020) Stock Price Struggling As A Result Of Its Mixed Financials?
Dec 29Here's Why Choong Ang Vaccine Laboratory (KOSDAQ:072020) Can Manage Its Debt Responsibly
Dec 08Here's What Choong Ang Vaccine Laboratory Co., Ltd.'s (KOSDAQ:072020) Shareholder Ownership Structure Looks Like
Nov 17Shareholder Returns
| A072020 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 3.1% | 6.9% | 5.2% |
| 1Y | -5.6% | 8.1% | -4.3% |
Return vs Industry: A072020 underperformed the KR Pharmaceuticals industry which returned 8.1% over the past year.
Return vs Market: A072020 underperformed the KR Market which returned -4.3% over the past year.
Price Volatility
| A072020 volatility | |
|---|---|
| A072020 Average Weekly Movement | 3.3% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A072020 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A072020's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 167 | In-Joong Yoon | www.cavac.co.kr |
Choong Ang Vaccine Laboratory Co., Ltd., operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea. Its vaccine products include SuiShot, PoulShot, CaniShot, BoviShot, FeliShot, RabbiShot, and AquaShot for preventing diseases and infection in pigs, poultry, dogs, cattle, cats, rabbits, and fish. The company was founded in 1968 and is based in Daejeon, South Korea.
Choong Ang Vaccine Laboratory Co., Ltd. Fundamentals Summary
| A072020 fundamental statistics | |
|---|---|
| Market cap | ₩97.21b |
| Earnings (TTM) | ₩3.65b |
| Revenue (TTM) | ₩39.19b |
0.0x
P/E Ratio0.0x
P/S RatioIs A072020 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A072020 income statement (TTM) | |
|---|---|
| Revenue | ₩39.19b |
| Cost of Revenue | ₩20.53b |
| Gross Profit | ₩18.66b |
| Other Expenses | ₩15.01b |
| Earnings | ₩3.65b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A072020 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 11:03 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Choong Ang Vaccine Laboratory Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Changhee Woo | IBK Securities Co. Ltd. |
| Sang-Yong Jeon | LS Securities Co., Ltd. |
| Tae Gi Ha | SK Securities Co., Ltd. |